-Reuters
Morgan Stanley Downgrades Oscar Health to Equal-Weight, Lowers Price Target to $5
Morgan Stanley analyst Ricky Goldwasser downgrades Oscar Health (NYSE:OSCR) from Overweight to Equal-Weight and lowers the price target from $9 to $5.